IGIB, New Delhi. FASc since 2024
Dr. Munia Ganguli is a Chief Scientist at the CSIR-Institute of Genomics and Integrative Biology, New Delhi, India, and a Professor at the Academy of Scientific and Innovative Research. She obtained her Master’s degree in Chemistry from Jadavpur University and earned her PhD in Solid State Chemistry from the Indian Institute of Science, Bengaluru. She subsequently pursued postdoctoral research at Philipps University, Marburg. For nearly two decades, Dr. Ganguli’s laboratory has focused on the development of nanomaterials for gene delivery and the application of nanotechnological tools, such as Atomic Force Microscopy, to investigate nanomorphologies and molecular interactions. A major area of her research involves the design and development of cell-penetrating peptides and biodegradable polymers for gene therapy and gene-editing applications. Dr. Ganguli has authored more than seventy research publications, holds several international patents, and has received multiple competitive research grants. She is a recipient of the National Bioscience Award for Career Development from the Department of Biotechnology (DBT), Government of India, in recognition of her contributions to nanobiotechnology. She has also been awarded the SERB-POWER Fellowship by the Department of Science and Technology (DST), which recognizes outstanding women researchers in India.
Session 1D: Inaugural Lectures by Fellows/Associates
Chairperson: Analabha Basu, NIBMG, Kalyani
Building Targeted Non-Viral Gene Delivery Systems
Nucleic acid-based therapeutics hold immense promise for transforming the treatment of a wide range of diseases. However, their successful clinical application depends on overcoming poor pharmacological properties through appropriate packaging and targeted release at the site of action. To address the challenges associated with nucleic acid delivery, non-viral vectors such as lipids, peptides, and polymers have been extensively developed and optimized for in vivo applications. Although significant progress has been made in the development of non-viral delivery systems, the design of an efficient gene delivery platform remains challenging and requires a thorough understanding of organ-specific delivery barriers and the rational modulation of carrier systems to overcome them. Our laboratory has developed peptide- and polymer-based gene delivery systems through rational design that can overcome both local and systemic barriers and facilitate delivery to organs such as the skin, lungs, muscle, and brain. The presentation will highlight the different strategies employed to achieve efficient and targeted delivery to these organs.